Piracetam for acute ischaemic stroke
Review of earlier studies · 2012
- What was studied
- Three trials, 1,002 patients; one trial supplied 93% of the data
- Main finding
- The review found insufficient evidence on dependence. A nonsignificant early-mortality trend was sensitive to baseline stroke-severity imbalance.
One-month death trend · Approximately 31% increase; interval from 5% reduction to 81% increase · Not statistically significant
Reported findings and study design
Three acute-stroke trials, 1,002 patients aged 40–85; one trial supplied 93% of the data. Search cutoff May 2011.
Population or model Three trials, 1,002 patients; one trial supplied 93% of the data
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| One-month death trend | Approximately 31% increase; interval from 5% reduction to 81% increase | Not statistically significant |
| After severity-imbalance adjustment | Unfavorable trend no longer apparent in the large trial | |
| Dependence/function | Insufficient evidence; limited data showed no difference |
The later page date does not indicate a newly searched trial set. Adverse effects were unreported, not proven absent.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- Condition-specific historical review, not a conclusion about healthy-person cognition.
- Harms were not adequately reported; absence of reporting is not evidence of safety.
- The review includes participants from the trials it summarizes.
Source details
Systematic review
Indexed abstract and included-trial list checked. The current Cochrane page dates the same DOI to 2022 but still reports a May 2011 search cutoff; this is not evidence of a newly searched trial set.
Abstract and reference list
Sources checked
Citation
S. Ricci, M. G. Celani, T. A. Cantisani, E. Righetti. Piracetam for acute ischaemic stroke Cochrane Database Syst Rev. 2012(9):CD000419
Study source ↗ · DOI 10.1002/14651858.CD000419.pub3 · Bibliography entry · Link to this summary